Form 4: Astrana Health COO and CFO Chandan Basho Receives Stock Grant

Chandan Basho, COO and CFO of Astrana Health, Inc., reports the acquisition of 26,701 shares of common stock through a restricted stock unit grant.

Summary

• On March 5, 2025, Chandan Basho, the COO and CFO of Astrana Health, Inc., acquired 26,701 shares of common stock through a grant of restricted stock units.
• These restricted stock units represent a contingent right to receive one share of Astrana Health's common stock each.
• The shares will vest in eight equal semi-annual installments beginning on September 5, 2025, contingent upon continuous employment with the Issuer.
• Following the reported transaction, Basho beneficially owns 192,752 shares of Astrana Health, Inc.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing related to executive compensation. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Positives

• The grant of restricted stock units aligns the executive's interests with the long-term performance of the company.
• The vesting schedule encourages continued employment with the Issuer.

Risks

• The vesting of the restricted stock units is contingent upon continuous employment with the Issuer, creating a potential risk if the executive leaves the company before the vesting dates.

Future Outlook

The document outlines the vesting schedule for the granted restricted stock units, indicating the future dates when the executive will receive the underlying shares, contingent upon continued employment.

Industry Context

Stock grants are a common form of executive compensation in the healthcare industry, aligning management's interests with shareholder value and incentivizing long-term performance.

Comparison to Industry Standards

• Stock grants are a typical component of executive compensation packages in publicly traded companies, particularly in the healthcare sector.
• Companies like UnitedHealth Group, CVS Health, and Anthem (now Elevance Health) also utilize stock grants and options as part of their executive compensation plans to incentivize performance and align management interests with shareholder value.
• The vesting schedules and grant sizes are generally benchmarked against industry peers to ensure competitiveness and retention.

Stakeholder Impact

• The stock grant could have a minor positive impact on shareholder value if it incentivizes the executive to improve company performance.
• The grant has a positive impact on the executive as part of their compensation.

Key Dates